Clinical implication of urinary protein markers in diabetic nephropathy and interventional effects of Chinese herbal medicine.
- Author:
Xi-Miao SHI
;
Xian-Jie MENG
;
Yi-Gang WAN
;
Shan-Mei SHEN
;
Xun-Yang LUO
;
Liu-Bao GU
;
Jian YAO
- Publication Type:Journal Article
- MeSH:
Biomarkers;
urine;
Diabetic Nephropathies;
complications;
drug therapy;
urine;
Drugs, Chinese Herbal;
pharmacology;
therapeutic use;
Humans;
Medicine, Chinese Traditional;
methods;
Proteinuria;
complications
- From:
China Journal of Chinese Materia Medica
2014;39(14):2589-2594
- CountryChina
- Language:Chinese
-
Abstract:
In clinic, some urinary protein makers can dynamically and noninvasively reflect the degree of renal tubular injury in patients with diabetic nephropathy (DN). These urinary biomarkers of tubular damage are broadly divided into two categories. One is newfound, including kidney injury molecule-1 (Kim-1), neutrophil getatinase-associated lipocalin (NGAL), liver-type fatty acid-binding protein (L-FABP) and cystatin C (CysC); the other one is classical, including beta2 microglobulin (beta2-MG), retinal binding protein (RBP) and N-acetyl-beta-D-glucosaminidase (NAG). It is reported that, the increases in urinary protein markers are not only closely related to the damage of tubular epithelial cells in DN patients, but also can be ameliorated by the treatment with Chinese herbal compound preparations or Chinese herbal medicine. Recently, although urinary proteomics are used in the protein separation and identification, the traditional associated detection of urinary protein markers is more practical in clinic. At present, it is possible that the associated detection of urinary biomarkers of glomerular and tubular damages may be a feasible measure to reveal the clinical significance of urinary protein markers in DN patients and the interventional effects of Chinese herbal medicine.
